医薬品分析展
AGC株式会社
AGCグループはグローバルにバイオ医薬品原薬の受託開発・製造事業を展開しています。豊富な実績と高度な技術に基づき、バイオ医薬品原薬の開発段階から商用段階までをサポートしています。
会社カテゴリー：原薬・添加剤・中間体、製造受託機関(CMO)、医薬品製造、再生医療関連
主サービス提供地域：日本、アメリカ合衆国、ヨーロッパ(イギリス以外)、イギリス、アジア
製品・サービス詳細
AGC Biologics develops analytical methods for product release, characterization, and process development support. Robust and validated release methods, including bioassays, are designed to ensure your product's identity, safety, purity, and potency.
Our in-house bioassay group specializes in the development and validation of cell-based assays. This speeds results and eliminates the need for third-party interactions.
Product Characterization
Our broad analytical characterization capabilities allow us to characterize carbohydrates, verify primary structure, identify post-translational modifications, and more. Our methods are applied to final product characterization, reference material qualification, and comparability studies.
We routinely coordinate our protein, cell therapy, and viral vector characterization activities with Process Development to monitor quality attributes throughout the development process.
With our talented staff, fully equipped labs, and extensive experience with molecules from antibodies to complex glycoproteins, to cell therapy and viral vector products, AGC Biologics is your number one resource for analytical characterization.
Key Analytical Development Capabilities
-
Potency assays
-
Carbohydrate analysis (quantitative sialic acid and monosaccharide analysis, N-glycan profiling)
-
Protein intact mass profiling by LC-TOF MS Peptide mapping by LC-MS/MS
-
SEC-MALLS for aggregate characterization
-
CD, fluorescence, and FTIR for secondary/tertiary structure characterization
-
HPLC and electrophoresis
-
Cellular-Based Assays and Stability Activities
-
160+ Custom In-House Analytical Tests for Clinical and Commercial Supply for Cell Therapy and Viral Vector products
While our analytical development services are part of a comprehensive development and manufacturing program, they can also be offered as standalone services. We develop analytical methods for protein biologics, cell therapy, and viral vector needs.